DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that the Dexcom G7 15 Day Continuous ...
I started monitoring my blood glucose levels by wearing a Libre while hospitalized after being diagnosed with Type 1 diabetes ...
First-of-its-kind NIL program features 27 athletes with Type 1 diabetes across 13 sports, marking the program’s largest roster to date Dexcom will host “Dexcom U Days” this fall to drive meaningful ...
Several analysts are maintaining buy ratings of Dexcom following a strong Q2 performance for the CGM company. Dexcom delivered 13% revenue growth to $1.3 billion while simultaneously demonstrating ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Dexcom G7 trims the sensor size, cuts warm-up to around 30 minutes and leans harder on phone-first glucose tracking for everyday diabetes care. This bestseller drives the price of Dexcom Inc. shares ...
Following up on its landmark FDA clearance for pediatric use earlier this month, Dexcom is backing up its newly expanded hardware reach with an AI-driven app overhaul. Unveiled at the Aspen Ideas: ...
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...
Every day there are new posts in a Facebook group — 89.5 thousand members strong — dedicated to Dexcom G7 issues and complaints. From inaccurate CGM readings and sensor failures to frustrating ...
Dexcom sponsored CONNECT randomized controlled trial expected to help establish new standard of care for CGM use by people with Type 2 diabetes not using insulin around the world. Showed use of Dexcom ...
DexCom focuses on continuous glucose monitoring (CGM) systems that allow people with diabetes to track glucose levels in real time without frequent fingersticks. The company operates within the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results